Skip to content
Menu

BridgeBio Pharma, Inc. BBIO

Full chart Compare
Set alert

Price alert · BBIO

All alert types
76.69 USD -0.67 (-0.87%)

As ofNov 17, 2026, 3:23 PM EST

74.75 Day range 77.10
63.30 52-week range 90.17
YTD
+0.26%
1 year
+14.63%

BBIO free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-447,007,000 USD

FY 2025 · Period ended

Coverage: incomplete. Values in USD; not inflation adjusted.

Capital expenditure is reported net of asset sales as an inflow for some periods; free cash flow is not shown for them.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Missing observations.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-447,007,00074,652,000Not meaningful
FY 20242024-12-31-521,659,0007,367,000Not meaningful
FY 20232023-12-31-529,026,000Not availableNot available
FY 20222022-12-31Not availableNot availableNot available
FY 20212021-12-31-511,180,000-103,948,000Not meaningful
FY 20202020-12-31-407,232,000-151,007,000Not meaningful
FY 20192019-12-31-256,225,000-117,404,000Not meaningful
FY 20182018-12-31-138,821,000-97,869,000Not meaningful
FY 20172017-12-31-40,952,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-08T14:24:23.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.